Evidence 1
Activity
Activity
≤5% Hemolysis
Toxicity
162.17±1.58 µg/mL
Hemolytic
Cytotoxic
≤5% Hemolysis | 162.17±1.58 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
N-terminal acetylation of antimicrobial peptide L163 improves its stability against protease degradation. | J Pept Sci | 2021